TGF-B1 expression has been suggested to be associated with YKL-40 expression, mediating many pathways involved in tumor progression and, importantly, acts together with IL-23 during the differentiation of Th17 cells, which are the main source of IL-17. The gene discussed is TGFB1; the disease is neoplasm.